Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer. Tsuboyama N, Wang R, Szczepanski AP, Chen H, et al. Oncogene 2022 Feb 22. pii: 10.1038/s41388-022-02240.

Read + Share

Amedeo Smart

Independent Medical Education

Tsuboyama N, Wang R, Szczepanski AP, Chen H, et al. Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer. Oncogene 2022 Feb 22. pii: 10.1038/s41388-022-02240.
PMID: 35194152